{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T05:17:31Z","timestamp":1791955051589,"version":"4.3.4"},"reference-count":24,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","transplantation-proceedings.org","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation Proceedings"],"published-print":{"date-parts":[[2015,9]]},"DOI":"10.1016\/j.transproceed.2015.06.003","type":"journal-article","created":{"date-parts":[[2015,9,8]],"date-time":"2015-09-08T22:02:22Z","timestamp":1441749742000},"page":"2295-2297","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["Successful Treatment of Chronic Hepatitis C Infection With Direct-Acting Antivirals in a Heart Transplant Recipient: A Case Report"],"prefix":"10.1016","volume":"47","author":[{"given":"S.","family":"Trakroo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Qureshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.transproceed.2015.06.003_bib1","doi-asserted-by":"crossref","first-page":"2353","DOI":"10.1016\/j.transproceed.2007.07.067","article-title":"Course of patients with chronic hepatitis C virus infection undergoing heart transplantation","volume":"39","author":"Cano","year":"2007","journal-title":"Transplant Proc"},{"key":"10.1016\/j.transproceed.2015.06.003_bib2","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/S1053-2498(00)00198-4","article-title":"Outcome of heart transplantation in patients previously infected with hepatitis C virus","volume":"20","author":"Castella","year":"2001","journal-title":"J\u00a0Heart Lung Transplant"},{"key":"10.1016\/j.transproceed.2015.06.003_bib3","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/S1053-2498(01)00255-8","article-title":"HBV and HCV infections in heart transplant recipients","volume":"20","author":"Fagiuoli","year":"2001","journal-title":"J\u00a0Heart Lung Transplant"},{"key":"10.1016\/j.transproceed.2015.06.003_bib4","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1097\/TP.0b013e3181bd3e59","article-title":"Impact of hepatitis C infection on outcomes after heart transplantation","volume":"88","author":"Fong","year":"2009","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2015.06.003_bib5","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1016\/j.healun.2011.06.003","article-title":"Decreased post-transplant survival among heart transplant recipients with pre-transplant hepatitis C virus positivity","volume":"30","author":"Lee","year":"2011","journal-title":"J\u00a0Heart Lung Transplant"},{"key":"10.1016\/j.transproceed.2015.06.003_bib6","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1111\/j.1432-2277.2008.00800.x","article-title":"New-onset diabetes mellitus after solid organ transplantation","volume":"22","author":"Bodziak","year":"2009","journal-title":"Transpl Int"},{"key":"10.1016\/j.transproceed.2015.06.003_bib7","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1097\/01.meg.0000231752.50587.ae","article-title":"Occurrence of post-transplant lymphoproliferative disorders among over thousand adult recipients: any role for hepatitis C infection?","volume":"18","author":"Burra","year":"2006","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.transproceed.2015.06.003_bib8","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1097\/TP.0b013e3181837761","article-title":"Incidence and risk factors for hepatocellular carcinoma after solid organ transplantation","volume":"86","author":"Hoffmann","year":"2008","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2015.06.003_bib9","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.cld.2005.05.006","article-title":"Treatment of hepatitis C in potential kidney and heart transplant patients","volume":"9","author":"Fabrizi","year":"2005","journal-title":"Clin Liver Dis"},{"key":"10.1016\/j.transproceed.2015.06.003_bib10","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.transproceed.2010.09.096","article-title":"Outcome of treatment with pegylated interferon and ribavirin in heart transplant recipients with chronic hepatitis C","volume":"43","author":"Durante-Mangonia","year":"2011","journal-title":"Transplant Proc"},{"issue":"12","key":"10.1016\/j.transproceed.2015.06.003_bib11","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1097\/01.TP.0000131151.07818.D7","article-title":"Ultralow-dose alpha-interferon plus ribavirin for the treatment of active hepatitis C in renal transplant recipients","volume":"77","author":"Shu","year":"2004","journal-title":"Transplantation"},{"issue":"1","key":"10.1016\/j.transproceed.2015.06.003_bib12","first-page":"958","article-title":"Renal allograft function in patients with chronic viral hepatitis B and C treated with interferon alpha","volume":"27","author":"Durlik","year":"1995","journal-title":"Transplant Proc"},{"key":"10.1016\/j.transproceed.2015.06.003_bib13","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1016\/j.athoracsur.2009.09.084","article-title":"Peginterferon alpha-2b and acute allograft failure in a heart transplant recipient","volume":"89","author":"Wang","year":"2010","journal-title":"Ann Thorac Surg"},{"issue":"suppl 4","key":"10.1016\/j.transproceed.2015.06.003_bib14","doi-asserted-by":"crossref","first-page":"S116","DOI":"10.1111\/j.1600-6143.2009.02902.x","article-title":"Viral hepatitis in solid organ transplant recipients","volume":"9","author":"Levitsky","year":"2009","journal-title":"Am J Transplant"},{"key":"10.1016\/j.transproceed.2015.06.003_bib15","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1056\/NEJMoa020047","article-title":"Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection","volume":"347","author":"Fried","year":"2002","journal-title":"N\u00a0Engl J Med"},{"issue":"10","key":"10.1016\/j.transproceed.2015.06.003_bib16","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1097\/00007890-199505270-00012","article-title":"Treatment of chronic hepatitis C with recombinant interferon alpha in kidney transplant recipients","volume":"59","author":"Rostaing","year":"1995","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2015.06.003_bib17","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1053\/j.gastro.2014.10.001","article-title":"Sofosbuvir and ribavirin for treatment of compensated recurrent hepatitis C virus infection after liver transplantation","volume":"148","author":"Charlton","year":"2015","journal-title":"Gastroenterology"},{"key":"10.1016\/j.transproceed.2015.06.003_bib18","first-page":"1269A","article-title":"Safety and efficacy of new DAA-based therapy for hepatitis C post-transplant: interval results from the HCV-TARGET longitudinal, observational study","volume":"60","author":"Brown","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.transproceed.2015.06.003_bib19","unstructured":"Thomas AM. SVR durability: HCV patients treated with IFN-free DAA regimens. Poster presented at: 2015 Conference on Retroviruses and Opportunistic Infections (CROI), February 23-26, 2015; Seattle, abstract\u00a0653."},{"key":"10.1016\/j.transproceed.2015.06.003_bib20","unstructured":"US Department of Health and Human Services. Scientific registry of transplant recipients. Available at: http:\/\/srtr.transplant.hrsa.gov\/annual_reports\/2012\/Default.aspx. Accessed February 23,\u00a02015."},{"key":"10.1016\/j.transproceed.2015.06.003_bib21","first-page":"917","article-title":"Policies regarding the transplantation of hepatitis C positive candidates and donor organs","volume":"16","author":"Lake","year":"1997","journal-title":"J\u00a0Heart Lung Transplant"},{"key":"10.1016\/j.transproceed.2015.06.003_bib22","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/j.cld.2006.08.025","article-title":"Hepatitis C in transplant recipients of solid organs, other than liver","volume":"10","author":"Wells","year":"2006","journal-title":"Clin Liver Dis"},{"key":"10.1016\/j.transproceed.2015.06.003_bib23","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1097\/01.TP.0000055834.67634.74","article-title":"Natural leukocyte interferon alfa for the treatment of chronic viral hepatitis in heart transplant recipients","volume":"75","author":"Fagiuoli","year":"2003","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2015.06.003_bib24","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1016\/S0041-1345(03)00368-3","article-title":"Five-year follow-up of hepatitis C-na\u00efve heart transplant recipients who received hepatitis C-positive donor hearts","volume":"35","author":"Gudmundsson","year":"2003","journal-title":"Transplant Proc"}],"container-title":["Transplantation Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134515005990?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134515005990?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,19]],"date-time":"2018-09-19T16:24:26Z","timestamp":1537374266000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041134515005990"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9]]},"references-count":24,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2015,9]]}},"alternative-id":["S0041134515005990"],"URL":"https:\/\/doi.org\/10.1016\/j.transproceed.2015.06.003","relation":{},"ISSN":["0041-1345"],"issn-type":[{"value":"0041-1345","type":"print"}],"subject":[],"published":{"date-parts":[[2015,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Successful Treatment of Chronic Hepatitis C Infection With Direct-Acting Antivirals in a Heart Transplant Recipient: A Case Report","name":"articletitle","label":"Article Title"},{"value":"Transplantation Proceedings","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.transproceed.2015.06.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}